Filing Details

Accession Number:
0001209191-20-038948
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-25 17:12:02
Reporting Period:
2020-06-23
Accepted Time:
2020-06-25 17:12:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1625101 Pulse Biosciences Inc. PLSE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1507650 Maky Zanganeh 3957 Point Eden Way
Hayward CA 94545
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-23 1,193 $10.70 106,767 No 4 P Indirect Immediate Family Member 1
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Immediate Family Member 1
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 352,500 Direct
Common Stock 27,000 Indirect Immediate Family Member 2
Common Stock 14,000 Indirect Immediate Family Member 3
Footnotes
  1. The Reporting Person's immediate family member received the shares from a banking institution as resolution to an error made by the institution in connection with a subscription order placed for the Issuer's rights offering. Such shares were not acquired directly from the Issuer.
  2. This is the weighted average purchase price of the shares, which ranged from $10.69 to $10.73 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.